Anavex Life Sciences (AVXL) Enterprise Value Growth (3y) (2013 - 2025)
Anavex Life Sciences (AVXL) Enterprise Value Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Anavex Life Sciences | 229.83 Mn | 98.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.84% |
| Sep 30, 2025 | 11.73% |
| Jun 30, 2025 | 12.92% |
| Mar 31, 2025 | 8.94% |
| Dec 31, 2024 | 7.20% |
| Sep 30, 2024 | 4.57% |
| Jun 30, 2024 | 4.15% |
| Mar 31, 2024 | -22.48% |
| Dec 31, 2023 | -44.80% |
| Sep 30, 2023 | -72.84% |
| Jun 30, 2023 | -77.64% |
| Mar 31, 2023 | -79.44% |
| Dec 31, 2022 | -73.59% |
| Sep 30, 2022 | -88.74% |
| Jun 30, 2022 | -93.14% |
| Mar 31, 2022 | -98.95% |
| Dec 31, 2021 | -93.82% |
| Sep 30, 2021 | -87.89% |
| Jun 30, 2021 | -82.72% |
| Mar 31, 2021 | -43.53% |